Bifidobacterium lactis GKK2, a composition comprising thereof and its use for improving allergic asthma
US11590180B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2019 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Oct 20, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a Bifidobacterium lactis GKK2, a composition comprising thereof and its use for improving asthma, especially for lowering airway resistance, reducing levels of non-specific and specific IgE in serum, alleviating bronchoconstriction and increasing levels of GSH reductase in liver tissue interstitial fluid to improve allergic asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.